kentucky glp-1 gastric stasis law office gastroparesis lawyer glp-1 gastroparesis in kentucky GLP-1 Lawsuit Attorneys 2026 Kentucky Labor Law Poster

April 18, 2026 Drugs Consultative Committee 68th meeting flags surrogate advertising of GLP-1 obesity drugs state regulators directed to enforce Medical Dialogues March 24, 2026 CDSCO tightens checks on generic semaglutide bans promotional activity, intensifies pharmacy surveillance Business Standard March 21, 2026 Patent expiry Day 1 8+ manufacturers launch simultaneously, prices fall up to 90% from branded versions CNBC March 17, 2026 ZydusLupin and ZydusTorrent licensing agreements announced ahead of patent expiry Pearce IP February 2026 Natco Pharma receives CDSCO approval for generic semaglutide Eris Lifesciences to commercialise Fierce Pharma December 2025 Sun Pharma receives first DCGI approval for generic semaglutide in India Noveltreat and Sematrinity Sun Pharma PR REGULATORY FRAMEWORK CDSCO Standards & Approval Requirements in India India's Central Drugs Standard Control Organisation (CDSCO) is the national drug regulator equivalent to the US FDA

Intended for laboratory and research purposes

Metastatic cells can escape the proapoptotic effects of TNF- through increased autocrine IL-6/STAT3 signaling

Glucagon-like peptide-1: a key regulator of innate immune function with clinical efficacy in a range of inflammatory diseases